A case report of targeted therapy with apatinib in a patient with recurrent high grade glioma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference19 articles.
1. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas;Ohgaki;J Neuropathol Exp Neurol,2005
2. Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway;Galan-Moya;EMBO Rep,2011
3. Mechanisms regulating glioma invasion;Paw;Cancer Lett,2015
4. VEGF manipulation in glioblastoma;Weathers;Oncology (Williston Park,2015
5. CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma;Smith;Acta Neuropathol,2012
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Personalized Medicine in Brain Gliomas: Targeted Therapy, Patient-Derived Tumor Models (Review);Sovremennye tehnologii v medicine;2023-06-29
2. Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option;Frontiers in Pharmacology;2022-08-17
3. Apatinib inhibits glioma cell malignancy in patient-derived orthotopic xenograft mouse model by targeting thrombospondin 1/myosin heavy chain 9 axis;Cell Death & Disease;2021-10
4. Clinical study of apatinib plus temozolomide for the treatment of recurrent high-grade gliomas;Journal of Clinical Neuroscience;2021-08
5. NDUFA4L2 promotes glioblastoma progression, is associated with poor survival, and can be effectively targeted by apatinib;Cell Death & Disease;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3